1·Of 37 patients with malaria, 10 had Vivax malaria and 27 had Falciparum malaria;
结果 37例疟疾病人中，10例为间日疟，27例为恶性疟；
2·Conclusion Naphthoquine phosphate is effective for the treatment of patients with Plasmodium falciparum malaria.
结论：磷酸萘酚喹治疗恶性疟疾具有良好的效果。
3·Objective To evaluate the clinical efficacy of dihydroartemisinin—mefloquine on acute uncomplicated falciparum malaria.
目的观察双氢青蒿素与甲氟喹联用治疗急性无并发症恶性疟疾的临床疗效。
4·WHO's treatment policy is to treat all cases of uncomplicated falciparum malaria with artemisinin combination therapy (ACTs).
世卫组织的治疗政策是，应采用青蒿素联合治疗药物来治疗一切无并发症的恶性疟疾病例。
5·Falciparum malaria-the most deadly type-is most common in sub-Saharan Africa, where it causes nearly a million deaths a year.
恶性疟疾—最致命的类型—在撒哈拉以南非洲最为常见，在那里每年造成将近100万人死亡。
6·Objective To evaluate the efficacy and side effects of artemether combined with primaquine in the treatment of falciparum malaria.
目的观察蒿甲醚伍用伯氨喹治疗恶性疟的疗效和副作用。
7·Objective To detect the risk factors for treatment failure of chloroquine against falciparum malaria in the border area in Yunnan, China.
目的 寻找在中国云南省边境地区氯喹治疗恶性疟失败的高危因素。
8·Falciparum malaria causes as many as 400 million infections a year and at least a million deaths, some 80 per cent of them in sub-Saharan Africa.
恶性疟每年造成多达4亿人感染和至少100万人死亡，其中约80%在撒哈拉以南非洲。
9·Objective To observe the therapeutic efficacy of compound dihydroartemisinin-piperaquine for treatment of uncomplicated falciparum malaria in Myanmar.
目的 观察双氢青蒿素哌喹复方片对缅甸无并发症恶性疟的疗效。
10·The resistance to the drug by Plasmodium parasites is a major problem for the effective treatment of malaria, especially Plasmodium falciparum malaria.
疟原虫尤其是恶性疟原虫对治疗药物产生抗药性是有效治疗疟疾面临的主要问题。